RFIDNews | VeriChip, RECEPTORS now in Phase II of developing glucose sensing RFID chip

Thursday, October 1, 2009

VeriChip and its partner RECEPTORS LLC announced that they will launch Phase II development of an implantable glucose-sensing RFID microchip. The goal of the project is to create an alternative way for diabetes patients to monitor blood sugar without the need to draw blood.

In Phase II of the program, which is expected to be completed in the second quarter of 2010, VeriChip and RECEPTORS will focus on optimizing the glucose sensor for system stability, sensitivity and specificity.

Past attempts at creating an in vivo glucose sensor have failed due to a number of reasons, communication limitations chief among them. VeriChip believes that an RFID chip contained within a millimeter-scale selectively porous, biocompatible membrane may be the answer.

If the technology proves successful, diabetes patients will be able to read their blood sugar with the simple wave of an RFID reader.

PositiveID completes development of embedded RFID glucose sensing system

PositiveID announced that it has completed development of its RFID glucose-sensing microchip, GlucoChip, which will accurately measure glucose levels in individuals with diabetes.

The lab tested a stable and reproducible closed cycle, continuous glucose sensing system that functions in the human blood fractions that are relevant to glucose sensing in the human body. According to the 2011 National Diabetes Fact Sheet, more than 25 million children and adults in the U.S. have diabetes, or over 8 % of the population.

PositiveID files patent for RF glucose monitoring system

PositiveID announced that it has filed a provisional patent application with the U.S. Patent and Trademark Office covering an interface that employs radio frequency communication for checking glucose levels.

VeriTeQ offers implantable microchip for traceability of breast implants and other medical devices

VeriTeQ announced its plans to offer the FDA-cleared VeriChip microchip, a rice grain-sized passive RFID microchip, for the identification of breast implants and other medical devices.

VeriChip chooses Raytheon/ECLAN to manufacture its microchips

VeriChip Corporation announced that it has selected Raytheon Microelectronics España/ECLAN for the production of the company’s implantable microchips, including the chip used in its HealthLink patient identification system, its new eight millimeter microchip for use in Medical Components Inc.’s vascular access medical devices, and its glucose-sensing RFID microchip under development with RECEPTORS LLC.

VeriTeQ acquires VeriChip implantable microchip, focuses on patient and animal ID

VeriTeQ announced it has acquired the VeriChip implantable microchip and related technologies and Health Link Web-based personal health record (PHR) from Positive ID. VeriChip is the FDA-cleared RFID implantable microchip for humans and patient identification.

VeriChip to present glucose-sensing chip at ID World Congress

VeriChip has announced that its chairman and chief executive officer, Scott R. Silverman, will present VeriChip’s in vivo glucose-sensing RFID chip at the ID World International Congress in Milan, Italy.

Subscribe

Print Magazine

Featured Events

Links

Searching …

VeriChip, RECEPTORS now in Phase II of developing glucose sensing RFID chip